In these uncertain times, it is more important than ever to connect and share ideas. The Law Over Lunch series offers FDLI members the exclusive opportunity to engage in facilitated virtual discussions over lunch on topics of interest to the food and drug law community. This event features unique and co-occurring discussion groups, limited to ten attendees to encourage fruitful conversation. This member-only benefit is a chance to closely learn from, educate, and network with other professionals in the field on new and pertinent topics.
Please only sign up for one discussion as they will take place at the same time.
Table Topics and Facilitators
What’s in a Name? Labeling of Plant-Based Food Products
Jacqueline Chan, Partner
Kleinfeld, Kaplan & Becker, LLP
The State of Intrastate CBD Regulations
Anastasia Gilmartin, Former Corporate Counsel at Docklight Brands
Summer Break: Movies and Shows in Summer 2020
Take a break from work topics and meet your peers over a fun and casual discussion of movies and shows from the summer of 2020. Joe Gitchell, President
Pinney Associates, Inc.
How to Introduce Clients to the FDA-Regulated Space: A Sharing Session
Colleen Heisey, Partner
Jones Day
JACQUELINE CHAN is a partner at Kleinfeld, Kaplan & Becker LLP. She advises all sizes of food companies from start-ups to global entities throughout the product lifecycle, including labeling, advertising/promotion, enforcement risk assessment, post-marketing obligations, and regulatory strategy and compliance. She serves as an active member of her clients’ teams, working to find solutions to meet both legal and business goals. Using her knowledge of today’s litigation trends, Ms. Chan helps develop new products, label claims, promotional campaigns, and advertising materials. She is currently keeping an eye on issues related to plant-based foods, standards of identity, and “green” claims. 
ANASTASIA GILMARTIN‘s legal background is almost entirely in cannabinoids. She started her career working in private practice at a boutique firm focused on recreational cannabis in Washington state. She then transitioned in house and was the sole attorney and regulatory lead for a Seattle based CBD start-up. Most recently, Anastasia worked as Corporate Counsel for Docklight Brands where she worked closely with sales and marketing to ensure that claims, packaging, and marketing materials were as compliant as possible with FDA, FTC, and state and local regulations. Anastasia also serves as Treasurer of the Washington State Bar Association’s Cannabis Law Section Executive Committee. She graduated from the University of Oregon with a Bachelor of Science degree in Psychology with a minor in business administration and earned her Juris Doctor and Master of Business Administration degrees from Seattle University.
JOSEPH (JOE) G. GITCHELL, President of Pinney Associates, has extensive experience providing strategic counsel to clients across a wide range of health policy, regulatory, and marketing and communications challenges. He has counseled clients navigating health policy and communications in the US, Europe, Latin America, Asia and the Middle East. This work has included extensive collaboration with highly respected researchers, policy experts, and nonprofit organizations around the world. Pinney Associates currently consults for RAI on an exclusive basis on smoking harm reduction matters. A co-author on over 40 articles, Joe has been published in journals including the American Journal of Preventive Medicine, Addiction, Archives of Internal Medicine, Morbidity and Mortality Weekly Report, and Tobacco Control. In addition, Joe has presented at industry and policy conferences, including the TMA, the Global Forum on Nicotine, and the CHPA Annual Executive Conference on topics including the impact of personal technologies on healthcare regulations and a strategic research agenda for e-cigarettes.
COLLEEN HEISEY is a partner at the law firm of Jones Day, where her practice focuses on food and drug law with an emphasis on product promotion and advertising, compliance counseling, good manufacturing practice requirements, product recalls, FDA inspection, competitor issues, and enforcement actions. She has advised on issues surrounding the regulation of drug, biological, food, dietary supplement, medical device, and cosmetic products by the FDA, USDA, and other federal and state agencies.August 20, 2020
12:00-1:00 PM
Registration is open to FDLI members only and is first come, first served.
This is a complimentary virtual event.
Please only sign up for one discussion as they will take place at the same time.
For questions, please contact Claire Day.
